SuperworthRoyalty Pharma shares outstanding RPRX
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 556.9M
- On a year earlier
- −1.0%
- fewer shares
Royalty Pharma had 556.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1.0% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 557.6M | −5% |
| FY2024 | 589.4M | −1% |
| FY2023 | 597.5M | +50% |
| FY2020 | 398.4M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 556.9M | −1% | |
| Q1 FY26 | 556.8M | −4% | |
| Q4 FY25 | 557.6M | −5% | |
| Q3 FY25 | 559.6M | −6% | |
| Q2 FY25 | 562.3M | −6% | |
| Q1 FY25 | 578.1M | −3% | |
| Q4 FY24 | 589.4M | −1% | |
| Q3 FY24 | 592.7M | −1% | |
| Q2 FY24 | 596.9M | −1% | |
| Q1 FY24 | 597.5M | −2% | |
| Q4 FY23 | 597.5M | n/a | |
| Q3 FY23 | 601.1M | −1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Royalty Pharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.